Glaukos Corporation · NYSE:GKOS

Glaukos — Q2 2022 Earnings Presentation

5 slides from Glaukos's earnings presentation, Aug 3, 2022

1. Slide 1: We'll Go First

   WE'LL GO FIRST Innovation is at the core of everything we do. At Glaukos, ‘we push the limite of science and technology to solve ‘unmet needs in chronic eye diseases. GLAUKOS ‘TRANSFORMING VISION

2. Slide 2: Franchise Revenue Performance

   ​ Franchise Revenue Performance

3. Slide 3: 2Q 2022 Revenue Mix

   2Q 2022 Revenue Mix Corneal Health $16.6M Glaucoma $38.2M International ‘Glaucoma $17.9M

4. Slide 4: Glaukos Pipeline Summary

   Glaukos Pipeline Summary Market Platform Product Indication US, Status (1) iPRIME Delivery of viscoelastic during ophthalmic surgery FDA Clearance Received iaccess Manual cutting of TM during ophthalmic surgery FDA Clearance Received ‘Mild-to-moderate primary open-angle glaucoma in istent iStent /iS

5. Slide 5: Additional Information

   Additional Information ​ ​ ​

Glaukos — Q2 2022 Earnings Presentation on 6ix